Wednesday, October 16, 2013 12:35:45 PM
If the results bear out the earlier animal tests it should get a very healthy increase in SP, IMHO. (upper 6's would be my GUESStimate) Next up (or maybe before) would probably be an announcement that the cGMP produciton facility was ready to start producing drug (or maybe broken down into had been completed but had to be validated, then one when it was validated) with a simultaneously announcement (or very shortly thereafter) that production had begun of the cGMP drug and an announcement that the data gathering tox testing had begun.
Much depends on how fine NNVC breaks it down into stages for PRs.
Events with MERS or H7N9 (further spread etc) could also have some effect (probably small unless an outbreak was highly significant)
If MERS spread thru the Hajj, that would become evident as a strong possibility within 2-3 weeks and a confirmed reality within a month or two, IMHO. (And I will begin forming a political action group to recall, prosecute and incarcerate as many involved congress(so called)"persons" as possible.
North Carolina has already started cutting social services. KIDS are going hungry and without medical care so that politicians can posture shamelessly and hold us all hostage.
I will NEVER fell the same about the USA again! We're right down there with Russia AFAIAC.
Recent NNVC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/27/2024 08:15:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM